GLP1R and type 2 diabetes mellitus: Sattar Sattar N N Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Lancet Diabetes Endocrinol Lancet Diabetes Endocrinol 2021 2021 9 9 10 10 653 653 662 662 supplied-pmid 34425083?